SCHEMBL10817064

SCHEMBL10817064

CCOC(=O)Nc1ccc(OC)c(OC)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.71
ALDH1A1 P00352 3/20 0.68
MEN1 O00255 1/20 0.66
GAA P10253 1/20 0.66
MAPT P10636 1/20 0.66
KMT2A Q03164 1/20 0.66
TSHR P16473 1/20 0.61
KDM4E B2RXH2 2/20 0.56
HPGD P15428 1/20 0.56
HSD17B10 Q99714 1/20 0.56
CYP1A2 P05177 3/20 0.56
CYP2C19 P33261 3/20 0.56
CYP2C9 P11712 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
FAAH O00519 1/20 0.55
KDR P35968 2/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17455071 0.92 ALDH1A1 (0.64) SMN1; SMN2ALDH1A1MEN1GAAMAPT
SCHEMBL10666473 0.89 ALDH1A1 (0.63) SMN1; SMN2ALDH1A1MEN1GAAMAPT
SCHEMBL10494904 0.88 ALDH1A1 (0.65) SMN1; SMN2ALDH1A1MEN1GAAMAPT
SCHEMBL11167696 0.88 ALDH1A1 (0.61) SMN1; SMN2ALDH1A1MEN1GAAMAPT
SCHEMBL10828250 0.85 FAAH (0.64) SMN1; SMN2ALDH1A1MEN1GAAMAPT
SCHEMBL2091191 0.84 SMN1; SMN2 (0.67) SMN1; SMN2ALDH1A1MEN1GAAMAPT
SCHEMBL15682719 0.84 MAPT (0.63) SMN1; SMN2ALDH1A1MEN1GAAMAPT
SCHEMBL10828257 0.84 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1MAPTTSHRKDM4E
SCHEMBL9472298 0.84 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1MEN1GAAMAPT
SCHEMBL28912292 0.83 KDM4E (0.61) SMN1; SMN2ALDH1A1MEN1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008152142-A1 2 -AMINOQUINAZOLINE DERIVATIVES AND THEIR THERAPEUTIC USES SOFTCURE PHARMACEUTICALS AB (SE) 2008-12-18 WO disclosed
EP-0210857-A1 Process for the preparation of alkyl 2-carboalkoxy-3,4-dialkoxybenzenecarbamates ORTHO PHARMACEUTICAL CORPORATION (US) 1987-02-04 EP disclosed
US-4617417-A Alkyl 2-carboalkoxy-3,4-dialkoxybenzenecarbamates and process for their preparation ORTHO PHARMACEUTICAL CORPORATION (US) 1986-10-14 US disclosed